Regulatory Approach of Biosimilars

Competitions and/or success in the present pharma industry is determined by the winning patent strategy which mostly pertain to the generic market entry. Generic and branded drug manufacturers both the patent strategy proximally belongs to the Hatch-Waxman Act statutory scheme and ANDA litigations. The Hatch-Waxman Act enacted in 1984 with amendment in 2003 facilitated the entry of generics at an early stage-thereby finishing the battle of branded generic ANDA of blockbuster drugs. All the same the Biologics Price Competition and Innovation (BPCI) Act has maximized the branded-generic patent duel in the biologics realm by imposing a litigated framework on follow-on-biologics. On September 16, 2011 President Obama signed the American Invents Act(AIA) of 2011 indicating a further strategy evolution of patenting branded and generics.

An FDA analysis of drug prices from 1999 to 2004 found that the discount from generic competition was just 6% with one generic competitor, but jumps to 48% with two generic competitors, 56% with three, 61% with four and 67% with five generic producers in a market. Within 2 years of the expiration of the patent of the popular drug Zantac in 1997, generics of Zantac accounted 90% of the treatment’s total sales, and the price for patients was about 10% of its pre-generic price. European patents on biologic treatments began to expire in 2000, and in April 2006, Sandoz and Biopartners successfully received EMEA approval for the first European biogenerics, two products containing human growth hormone.

  • Licensing of biosimilars
  • BLA filing for biosimilars
  • Regulatory prospects of BRIC countries
  • Biowaiver approval for biosimilars

Related Conference of Regulatory Approach of Biosimilars

August 22-23, 2022

2nd Annual Congress on Hospital and Clinical Pharmacy

Dublin, Ireland
August 24-25, 2022

5th International Conference on Neonatology and Perinatology

Prague, Czech Republic
August 25-26, 2022

International Conference on Bio Pharmaceutics

Yokohama, Japan
August 28-28, 2022

8th Webinar on Pharmacology and Toxicology

London, UK
August 30-31, 2022

21st Medicinal & PharmaceuticalSciences Congress

Osaka, Japan
September 02-03, 2022

37th World Congress on Pharmacology and Therapeutics

Stockholm, Sweden
September 05-06, 2022

19th International Conference on Pharmaceutical Chemistry

Paris, France
September 12-13, 2022

World Congress on Medicinal Chemistry and Computer Aided Drug Design

Prague, Czech Republic
September 16-17, 2022

2nd Natural Medicines and Pharmaceutical Research

New York, USA
September 22-23, 2022

Pharma Biotech Expo 2022

Toronto, Canada
September 29-30, 2022

2nd World Congress on Rare Diseases & Orphan Drugs

Lisbon, Portugal
September 29-30, 2022

7th International Conference on Future Pharma and Innovations

Lisbon, Portugal
October 05-06, 2022

2nd International Congress on Drug Delivery

Bangkok, Thailand
October 10-11, 2022

18th Annual Congress on Pharmacology and Toxicology

Paris, France
October 17-18, 2022

3rd Annual Congress on Antibiotics and Bacterial Infections

Prague, Czech Republic
October 24-25, 2022

22nd Annual Pharma Middle East Congress

Dubai, UAE
October 24-25, 2022

17th World Conference on Pharmaceutical Chemistry

Dublin, Ireland
November 10-11, 2022

2nd World Biosimilars & Biologics Congress

Vancouver, Canada
November 15-16, 2022

10th International Conference on Clinical Trials

Barcelona, Spain
November 16-17, 2022

2nd World Congress on Biologics and Biosimilars

Hanoi, Vietnam
November 21-22, 2022

24th World Congress On Pharmaceutical Research and Drug Discovery

Singapore City, Singapore
November 22-23, 2022

European Conference on Advance Clinical Trials and Research

Amsterdam, Netherlands
December 05-06, 2022

World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 07-08, 2022

9th Asian Herbal and Traditional Medicine summit

Paris, France
December 07-08, 2022

14th World Congress on Personalized Medicine and Novel Therapy

Singapore City, Singapore
December 12-13, 2022

5th International Pharmacy and Pharmaceutical Conference

Dublin, Ireland
March 10-11, 2023

Global Pharmaceutical and Pharma Industry Conference

Brussels, Belgium
March 13-14, 2023

33rd Annual European Pharma Congress

Frankfurt, Germany
April 03-04, 2023

16th European Biosimilars Congress

Barcelona, Spain
May 07-08, 2023

Advanced-Materials 2023

Valencia, Spain
May 22-23, 2023

3rd Global Summit on Pharmaceutical Research

Berlin, Germany
May 24-25, 2023

8th Pharmaceutical Chemistry Conference

Paris, France

Regulatory Approach of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in